| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 10.03M | 58.28% |
| Operating expense | — | — |
| Net income | 736.97K | 108.88% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RK7.F returned -39.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -18.7% |
| 1 year | -39.1% |
| All-time high | €2.47 (Aug 2022) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in RK7.F would be worth today ›No. Laboratorio Farmaceutico Erfo S.p.A. has not paid a dividend in the past 12 months.
Laboratorio Farmaceutico Erfo S.p.A. is part of the Consumer Defensive sector.
Laboratorio Farmaceutico Erfo S.p.A. has a market cap of 8.28M EUR, based on the latest quote.
